$OCAT

What is Astellas Pharma, the purchaser of Ocata?

Fish-eating-fish

Astellas Pharma is on track to purchase Ocata Therapeutics (formerly Advanced Cell Technology). This has stirred a lot of strong feelings amongst investors in Ocata. (Update, now almost 5 years later, the Ocata vision program is still not going full steam ahead at its new owner it seems). I’ve also been wondering what exactly is …

What is Astellas Pharma, the purchaser of Ocata? Read More »

Tale of 7 stem cell biotech stock woes

Ocata

To get from point A of a stem cell discovery to point B of a patient actually receiving a treatment based on that discovery is a long and non-linear road, which requires biotech company research. Stem cell biotech companies including publicly traded companies are an integral part of the field making that journey. How those …

Tale of 7 stem cell biotech stock woes Read More »

Monday morning musings: stocks, ISSCR, grants, CRISPR, New Book

Wake-up-its-Monday

What’s on your mind on this Monday morning and are you caffeinated enough yet? Depending on where you live it may even be time for dinner, bed, or already early Tuesday. Here are some Monday musings… To get safe and effective stem cell treatments to patients in a responsible, compliant manner you need commercial efforts …

Monday morning musings: stocks, ISSCR, grants, CRISPR, New Book Read More »